NCC patient plasma analysis has some limitations: (a) the cohort size in the analysis was small, (b) some of the osteolytic group patients had both osteolytic and osteoblastic bone metastasis, and (c) α1ACT and LCN2 are known as biomarkers of other diseases. This evidence concerns the gene LCN2 and bone metastasis.